Title: Warner A, et, al. Development of a purity control strategy for pemetrexed disodium and validation of associated analytical methodology. J Pharm Biomed Anal. 2015 Feb;105:46-54.
137281-23-3
150399-23-8
357166-29-1
146943-43-3
155405-81-5
357166-30-4
873841-43-1 | 2-(1-Hydroxypentyl)-6-Methyl-3-(2-phenylethyl)-1H-indole-5-carboxylic Acid | AA00GXWY | MFCD27978011
886762-45-4 | 4-(4-Fluorophenoxy)iodobenzene | AA00GYB3 | MFCD07368761
914637-05-1 | 3,3,4,4,5,5,6,6,7,7,7-Undecafluoroheptan-2-ol | AA00GZLZ | MFCD08460482
864377-28-6 | 4-(3-Bromophenyl)-2,6-diphenylpyrimidine | AA00H05R | MFCD28962150
88930-15-8 | (10α,24R)-9β-Methyl-19-norlanosta-5-ene-3β,11α,24,25-tetrol | AA00H0P3 | MFCD29904541
894807-98-8 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1h-pyrazole | AA00H0XW | MFCD20486100
91143-71-4 | 2-(4-Acetylphenoxy)propanoic acid | AA00H1AF | MFCD06356477
904326-88-1 | 2-Methylaminopyrimidine-5-boronic acid, pinacol ester | AA00H1P2 | MFCD11878345
885950-17-4 | 2-(4-FLUOROPHENYL)NICOTINALDEHYDE | AA00H1WR | MFCD06659613
869718-80-9 | MPEG8-N3 | AA00H20D | MFCD13184962